QUOC NGUYEN: Open Payments
NPI 1376076596 · GARLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$959 in 39 payments from 14 companies in 2025. Trend: 2023 $901 · 2024 $849 · 2025 $959
Food & beverage: $959
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 7 | $163 |
| ABIOMED | 4 | $159 |
| PFIZER INC. | 8 | $153 |
| Actelion Pharmaceuticals US, Inc. | 4 | $130 |
| E.R. Squibb & Sons, L.L.C. | 3 | $79 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $57 |
| Novartis Pharmaceuticals Corporation | 2 | $43 |
| Kestra Medical Technology Services, Inc. | 1 | $40 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $37 |
| Novo Nordisk Inc | 1 | $30 |
Products named: VERQUVO, UPTRAVI, VYNDAQEL, ELIQUIS, Adempas, CAMZYOS, LEQVIO, Assure WCD.
Industry payments across TX — which companies pay providers there.
